Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.43 |
| ▸ | KDM4E | B2RXH2 | 5/20 | 0.43 |
| ▸ | GAA | P10253 | 2/20 | 0.43 |
| ▸ | GLA | P06280 | 1/20 | 0.43 |
| ▸ | HPGD | P15428 | 2/20 | 0.42 |
| ▸ | KCNA3 | P22001 | 1/20 | 0.40 |
| ▸ | LMNA | P02545 | 1/20 | 0.39 |
| ▸ | RECQL | P46063 | 1/20 | 0.39 |
| ▸ | MEN1 | O00255 | 1/20 | 0.38 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.38 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.38 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.37 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.37 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.37 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.37 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL21533758 | 0.94 | KDM4E (0.45) | ALDH1A1KDM4EGAAGLAHPGD | |
| SCHEMBL24820151 | 0.86 | NPC1 (0.42) | ALDH1A1KDM4EGAAHPGDLMNA | |
| SCHEMBL21171750 | 0.84 | ACHE (0.48) | ALDH1A1KDM4EGAAGLAHPGD | |
| SCHEMBL21171772 | 0.84 | ALDH1A1 (0.42) | ALDH1A1KDM4EGAAHPGDKCNA3 | |
| SCHEMBL3918141 | 0.80 | KCNA3 (0.60) | KCNA3 | |
| SCHEMBL21171972 | 0.79 | ALDH1A1 (0.43) | ALDH1A1KDM4EGAAHPGDRECQL | |
| SCHEMBL24487254 | 0.78 | NQO1 (0.43) | ALDH1A1KDM4EGAAGLAHPGD | |
| SCHEMBL24487071 | 0.78 | KDM4E (0.44) | ALDH1A1KDM4EGAAGLAHPGD | |
| SCHEMBL19636623 | 0.78 | PON1 (0.50) | ALDH1A1KDM4EGAAGLAHPGD | |
| SCHEMBL3918098 | 0.76 | KCNA3 (0.57) | KCNA3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11352325-B2 | Rapid fluorescence tagging of glycans and other biomolecules with enhanced MS signals | WATERS TECHNOLOGIES CORPORATION (US) | 2022-06-07 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11352325-B2 | Rapid fluorescence tagging of glycans and other biomolecules with enhanced MS signals | FUT5, FUT6, ST3GAL3 | ALDH1A1 1650/4885KDM4E 2975/4885GAA 190/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.